This “Microfluidics Market” report 2019-2024 provides an in-depth analysis of the current trends and future approximations to represent the forthcoming investment plans. The Microfluidics market report presents the vendor landscape and consistent detailed analysis of the major vendors operating in the market. The report provides a competitive environment of the Microfluidics market is based on company profiles and their efforts on increasing product value and production.
The Report Covers:
- Comprehensive research methodology of Microfluidics market
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Microfluidics market
- Insights about market determinants which are inspiring the Microfluidics market
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players Companies Mentioned
For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999539
Key Questions Answered in This Report:
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints on category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
Key Market Trends:
Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment
In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.80% during the forecast period.
A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient’s blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.
So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market’s growth.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R&D. Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.
Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999539
Detailed TOC of Microfluidics Market 2019-2024:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Point-of-care Testing
4.2.2 Increasing Incidences of Chronic Diseases
4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
4.3 Market Restraints
4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process
4.3.2 Low Adoption in Developing Countries due to High Prices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Component
5.1.1 Microfluidic Chips
5.1.2 Micro Pumps
5.1.3 Micro Needles
5.1.4 Other Components
5.2 Application
5.2.1 Drug Delivery
5.2.2 High-throughput Screening
5.2.3 Point-of-Care Diagnostics
5.2.4 Lab Analytics
5.2.4.1 Proteomics
5.2.4.2 Genomics
5.2.4.3 Cell-based Assay
5.2.4.4 Capillary Electrophoresis
5.2.5 Clinical Diagnostics
5.3 Material
5.3.1 Polymer
5.3.2 Silicone
5.3.3 Glass
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-LA Roche Ltd
6.1.3 Agilent Technologies
6.1.4 Danaher Corporation (Cepheid)
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 PerkinElmer Inc.
6.1.8 FluIdigm Corporation
6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd)
6.1.10 Micronit Microfluidics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Contact Us:
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports:
